AzTrials
AzTrials

Bell's PalsyNCT05707091

Low Laser Therapy on Facial Motor Functions Function and Synkinesis in Patients With Bell's Palsy

A study testing Low level laser therapy and conventional therapy and Conventional therapy in people with Bell's Palsy, run by Riphah International University at 1 site in Pakistan.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

To determine the effects of low-level laser therapy on facial motor functions and synkinesis in patients with bell's palsy Read more about this study

Who is it for?
Ages 30 to 60 years
Conditions the study is for
Bell's Palsy
What is being tested?
Low level laser therapy and conventional therapy and Conventional therapy
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
32 participants
Where
1 sitePakistan
Study dates
1 Jan 2023to 1 Mar 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Male female diagnosed with idiopathic Bell's palsy by physician
  • age 30-60years
  • Bell's palsy in patients having known history of hypertension
  • Bell's palsy in patients having known history of diabetes

Who cannot join

  • Participants with a middle ear infection
  • parotid gland tumor
  • malignant otitis external
  • Tumors in the base of the lateral skull
  • upper motor neuron facial palsy
  • segmental muscle weakness
  • and recurrent episodes of facial paralysis, polyneuropathies

Trial locations and contacts

1 site in 1 country.

Ali Raza, MsOMPT contact

03326099065

araza.frahs@riphah.edu.pk

Pakistan1 site, 1 recruiting
  • Ali raza

    Lahore, Punjab Province

    Ali Raza, MsOMPT, 03326099065, araza.frahs@riphah.edu.pk

    Recruiting

Other trials in Pakistan

About this study

Official title: Effects of Low Laser Therapy on Facial Motor Functions Function and Synkinesis in Patients With Bell's Palsy

To determine the effects of low-level laser therapy on facial motor functions and synkinesis in patients with bell's palsy

Read the detailed description

A randomised controlled trial tested low-level laser therapy (LLLT) for bell's palsy. Lahore's Ittefaq Hospital selected 32 bell's palsy patients for the research. The Facial Disability Index (FDI), House-Brackmann Scale (HBS), and Sunnybrook Facial Grading System were used to collect data over ten months (SFG). LLLT and conventional therapy were randomly assigned to two groups. SPSS 25 compared pre- and post-treatment values of the two groups.

Conditions
Bell's Palsy
Being tested
Low level laser therapy and conventional therapy, Conventional therapy
Medical subject headings
Bell Palsy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Low level laser therapy and conventional therapyOther

    One group treated with low level laser therapy along with conventional therapy

  • Conventional therapyProcedure or surgery

    Group B treated with ems and exercises

Study groups in NCT05707091
Study groupRoleWhat they receive
Low level laser therapyExperimentalPatients assigned to experimental group received low level laser therapy and conventional therapy. Treatment frequency was five sessions/week for 4 weeks. . For laser therapy, Omega laser system used with infrared probes of 830 nm wavelength and 100 mW output power, average energy density of 10 J/cm2 , frequency of 1 KHz, and a duty cycle of 80 % in one group. In all cases, the laser was in direct contact with the superficial roots of the facial nerve on the affected side. And was applied for 2 min and 5 s per point for 8 points.
Receives: Other: Low level laser therapy and conventional therapy
Conventional therapyExperimentalGroup B was treated with conventional therapy. The interrupted galvanic electrical impulses with the duration of 3-30 milliseconds, the tolerable intensity was applied over the motor points of each facial muscle. A total of 30-60 electrical twitch induced muscle contractions will be maintained for each muscle. The facial muscles exercise training with mirror-visual feedback was progressed to resisted exercises by self and/or therapist-assistance. All exercises were demonstrated to participants by the therapist's efforts and instructed the participants to continue the exercises twice a day for 10-15 minutes. A pictorial leaflet of facial expressions exercises with appropriate instructions to perform exercises. Treatment frequency was five sessions/week for 4 weeks.
Receives: Procedure: Conventional therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Facial disability index

    To access the physical well-being

    Measured: 4 weeks

  2. Housebrackmann scale

    To grade the facial muscle weakness

    Measured: 4 weeks

  3. Sunnybrook facial grading

    To acess symmetry and synkinesis

    Measured: 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Jan 2023
  2. Study start1 Jan 2023
  3. Primary completion1 Mar 2023 (estimated)
  4. Study completion1 Mar 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
32 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05707091
Sponsor's protocol ID
REC/RCR&AHS/22/0216
Status last verified
Jan 2023
First submitted
22 Jan 2023
Last updated
31 Jan 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Aghamohamdi D, Fakhari S, Farhoudi M, Farzin H. The Efficacy of Low-Level Laser Therapy in the Treatment of Bell's Palsy in Diabetic Patients. J Lasers Med Sci. 2020 Summer;11(3):310-315. doi: 10.34172/jlms.2020.52. Epub 2020 Jun 21.

    PubMed 32802293
  • Ordahan B, Karahan AY. Role of low-level laser therapy added to facial expression exercises in patients with idiopathic facial (Bell's) palsy. Lasers Med Sci. 2017 May;32(4):931-936. doi: 10.1007/s10103-017-2195-9. Epub 2017 Mar 23.

    PubMed 28337563
  • de Oliveira RF, da Silva AC, Simoes A, Youssef MN, de Freitas PM. Laser Therapy in the Treatment of Paresthesia: A Retrospective Study of 125 Clinical Cases. Photomed Laser Surg. 2015 Aug;33(8):415-23. doi: 10.1089/pho.2015.3888.

    PubMed 26226172
  • Alayat MS, Elsodany AM, El Fiky AA. Efficacy of high and low level laser therapy in the treatment of Bell's palsy: a randomized double blind placebo-controlled trial. Lasers Med Sci. 2014 Jan;29(1):335-42. doi: 10.1007/s10103-013-1352-z. Epub 2013 May 26.

    PubMed 23709010
  • Bylund N, Hultcrantz M, Jonsson L, Marsk E. Quality of Life in Bell's Palsy: Correlation with Sunnybrook and House-Brackmann Over Time. Laryngoscope. 2021 Feb;131(2):E612-E618. doi: 10.1002/lary.28751. Epub 2020 May 28.

    PubMed 32463963

Questions about this trial

What is this clinical trial studying?

A study testing Low level laser therapy and conventional therapy and Conventional therapy in people with Bell's Palsy, run by Riphah International University at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 31 Jan 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ali Raza, MsOMPT (03326099065, araza.frahs@riphah.edu.pk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Facial disability index (time frame: 4 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05707091, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Jan 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in